IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vivo Capital, LLC

Q4 2016 Holdings

Filed 2017-02-14 | 25 holdings | $149.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2017-04-06) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris therapeutics(ACRS)Common00461U105$89.1M3,283,56959.7%
Ascendis Pharma(ASND)ADR04351P101$35.8M1,766,83223.9%
Codexis, Inc.(CDXS)Common192005106$24.4M5,294,82516.3%
Nabriva Therapeutics AGADR62957M104$24.0K4,021,5590.0%
Eiger BioPharmaceuticals(CLDNEUR)Common28249U105$20.8K1,787,0910.0%
Aimmune Therapeutics, Inc.(AIMT)Common00900T107$15.6K763,0090.0%
Advanced Accelerator Applications S.A.Common00790T100$12.2K455,7980.0%
Trevena, Inc.Common89532E109$10.2K1,728,0000.0%
Foamix Pharmaceuticals Ltd.CommonM46135105$9.5K855,0000.0%
Regenxbio Inc.(RGNX)Common75901B107$9.3K502,8630.0%
Agile Therapeutics, Inc.(AGRXUSD)Common00847L100$8.6K1,513,9750.0%
CoLucid Pharmaceuticals, Inc.Common19716T101$8.2K225,0000.0%
Strongbridge Biopharma plcOrdinary SharesG85347105$7.2K3,000,0000.0%
Capnia, Inc.Common14066L105$6.0K7,456,9840.0%
BioPharmX CorporationCommon09072X101$4.8K12,814,2860.0%
Akari Therapeutics PlcADR00972G108$3.7K527,8420.0%
ProNAi Therapeutics, Inc.Common74346L101$3.6K2,438,2700.0%
Crispr Therapeutics AG(CRSP)ACommonH17182108$3.0K148,8780.0%
KalVista Pharmaceuticals, Inc.(KALV)Common483497103$2.1K300,3250.0%
Sunesis Pharmaceuticals, Inc.Common867328700$1.8K500,0000.0%
ReVance Therapeutics, Inc.(RVNCEUR)Common761330109$1.6K77,3730.0%
Dynavax Technologies Corporation(DVAX)Common268158201$1.4K359,8280.0%
Ocera Therapeutics, Inc.Common67552A108$322153,3310.0%
Zosano Pharma CorpCommon98979H103$7798,5150.0%
Capnia, Inc.Warrant14066L113$76943,8580.0%